Science Explorer Back to mapMap
Discussion
Institution · Ospedale Humanitas Gradenigo

Most cited papers from Ospedale Humanitas Gradenigo

Ospedale Humanitas Gradenigo

What are the most cited papers from Ospedale Humanitas Gradenigo?

The most cited paper from Ospedale Humanitas Gradenigo is "Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity" (Giovanni Musso, Roberto Gambino, Maurizio Cassader et al., 2010), with 1,307 citations. Next come "Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis" (729) and "Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)" (686).

Showing 50 of 60 papers. Every paper with more than 84 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity Giovanni Musso, Roberto Gambino, Maurizio Cassader et al. · Annals of Medicine Open access 2 Nov 2010 1,307
2 Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis Giovanni Musso et al. · PLoS Medicine ReviewOpen access 22 Jul 2014 729
3 Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD) Giovanni Musso, Richard J. Gambino, M. Cassader · Progress in Lipid Research 10 Sep 2008 686
4 Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials Giovanni Musso, Maurizio Cassader, Floriano Rosina et al. · Diabetologia ReviewOpen access 26 Jan 2012 675
5 Obesity, Diabetes, and Gut Microbiota Giovanni Musso, Roberto Gambino, Maurizio Cassader · Diabetes Care Open access 28 Sep 2010 675
6 Interactions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes Giovanni Musso, Roberto Gambino, Maurizio Cassader · Annual Review of Medicine Review 26 Jan 2010 610
7 Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology Wouter van Rheenen et al. · Nature Genetics Open access282 authors Dec 2021 579
8 A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease Giovanni Musso, Roberto Gambino, Maurizio Cassader et al. · Hepatology ReviewOpen access Mar 2010 566
9 Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis Giovanni Musso, Maurizio Cassader, Elena Paschetta et al. · JAMA Internal Medicine Open access 27 Feb 2017 439
10 Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies Giovanni Musso, Maurizio Cassader, Roberto Gambino · Nature Reviews Drug Discovery Review 22 Jan 2016 422
11 Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis Giovanni Musso, Roberto Gambino, Maurizio Cassader · Progress in Lipid Research Open access Dec 2012 417
12 Surgery in COVID-19 patients: operational directives Federico Coccolini et al. · World Journal of Emergency Surgery Open access 7 Apr 2020 415
13 Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis Xiangdong Liu et al. · Nature Genetics Open access 18 Jul 2010 399
14 Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis Giovanni Musso, Maurizio Cassader, Elena Paschetta et al. · Gastroenterology 12 Jun 2018 334
15 A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials Giovanni Musso, Roberto Gambino, Maurizio Cassader et al. · Annals of Medicine ReviewOpen access 15 Apr 2011 287
16 Association of obstructive sleep apnoea with the presence and severity of non‐alcoholic fatty liver disease. A systematic review and meta‐analysis Giovanni Musso, M. Cassader, Carla Olivetti et al. · Obesity Reviews ReviewOpen access 6 Feb 2013 253
17 Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence? Antonio Sircana, Luciana Framarin, Nicola Leone et al. · Current Diabetes Reports 12 Sep 2018 234
18 Colonic stenting as a bridge to surgery versus emergency surgery for malignant colonic obstruction: results of a multicentre randomised controlled trial (ESCO trial) Alberto Arezzo, Carmen Balagué, Eduardo M. Targarona et al. · Surgical Endoscopy 6 Dec 2016 208
19 Non‐alcoholic fatty liver disease from pathogenesis to management: an update Giovanni Musso, Roberto Gambino, Maurizio Cassader · Obesity Reviews Open access 21 Oct 2009 200
20 Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome? Giovanni Musso, Roberto Gambino, Simona Bo et al. · Diabetes Care Open access 28 Feb 2008 198
21 Short, Full-Dose Adjuvant Chemotherapy in High-Risk Adult Soft Tissue Sarcomas: A Randomized Clinical Trial From the Italian Sarcoma Group and the Spanish Sarcoma Group Alessandro Gronchi, Sergio Frustaci, Mario Mercuri et al. · Journal of Clinical Oncology 7 Feb 2012 191
22 Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life Marco Cesare Maltoni et al. · European Journal of Cancer Open access 4 Nov 2016 189
23 Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders Giovanni Musso, Roberto Gambino, Maurizio Cassader · Current Opinion in Lipidology Open access 23 Jan 2010 187
24 Consuming More of Daily Caloric Intake at Dinner Predisposes to Obesity. A 6-Year Population-Based Prospective Cohort Study Simona Bo, Giovanni Musso, Guglielmo Beccuti et al. · PLoS ONE Open access 24 Sep 2014 168
25 Extensive genetics of ALS Adriano Chiò et al. · Neurology Open access 26 Oct 2012 165
26 Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities Giovanni Musso, Maurizio Cassader, Solomon J. Cohney et al. · Diabetes Care Open access 13 Sep 2016 162
27 Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities Roberto Gambino, Giovanni Musso, Maurizio Cassader · Antioxidants and Redox Signaling 24 Oct 2010 151
28 LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease Sara Ceccarelli, Nadia Panera, Marco Mina et al. · Oncotarget Open access 8 Oct 2015 148
29 Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE) Andrea Maria Isidori, Antônio Aversa, Aldo Eugenio Calogero et al. · Journal of Endocrinological Investigation Open access 26 Aug 2022 147
30 Obstructive Sleep Apnea Syndrome Affects Liver Histology and Inflammatory Cell Activation in Pediatric Nonalcoholic Fatty Liver Disease, Regardless of Obesity/Insulin Resistance Valério Nobili, Renato Cutrera, Daniela Liccardo et al. · American Journal of Respiratory and Critical Care Medicine 20 Nov 2013 139
31 Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat Giovanni Musso, Roberto Gambino, Franco De Michieli et al. · Hepatology Open access 29 Feb 2008 135
32 Human leukocyte antigen polymorphisms in italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls Pietro Invernizzi, Carlo Francesco Selmi, Francesca Poli et al. · Hepatology Open access 5 Aug 2008 134
33 Emerging Liver–Kidney Interactions in Nonalcoholic Fatty Liver Disease Giovanni Musso, Maurizio Cassader, Solomon J. Cohney et al. · Trends in Molecular Medicine Review 29 Sep 2015 132
34 Treatment of hepatitis D Grazia Anna Niro, Floriano Rosina, Mario Rizzetto · Journal of Viral Hepatitis 2005 131
35 Changing pattern of chronic hepatitis D in Southern Europe Floriano Rosina, P. Conoscitore, Renato Cuppone et al. · Gastroenterology Open access Jul 1999 127
36 Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal A. Cassinotti, Giovanni Clemente Actis, Piergiorgio Duca et al. · The American Journal of Gastroenterology 21 Jul 2009 127
37 EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma Stefano A. Ferrari et al. · Tumori Journal 8 Dec 2017 126
38 Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism Giovanni Musso, Maurizio Cassader, Franco De Michieli et al. · Hepatology 8 Jun 2012 126
39 A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study Armando Santoro, Vittorio Gebbia, Tiziana Pressiani et al. · Annals of Oncology Open access 24 Dec 2014 117
40 Polymorphism in microsomal triglyceride transfer protein Roberto Gambino, Maurizio Cassader, Gianfranco Pagano et al. · Hepatology Open access 26 Apr 2007 117
41 Tumor response assessment by modified Choi criteria in localized high‐risk soft tissue sarcoma treated with chemotherapy Silvia Stacchiotti, Paolo Verderio, A. Messina et al. · Cancer Open access 17 May 2012 110
42 Prolonged saturated fat–induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver Giovanni Musso, Roberto Gambino, Giovanni Pacini et al. · American Journal of Clinical Nutrition Open access 14 Jan 2009 109
43 Separation surgery for metastatic epidural spinal cord compression: A qualitative review Giuseppe Di Perna, Fabio Cofano, Cristina Mantovani et al. · Journal of bone oncology Open access 26 Sep 2020 104
44 Diabetic ketoacidosis with SGLT2 inhibitors Giovanni Musso, Francesca Saba, Maurizio Cassader et al. · BMJ Open access 12 Nov 2020 103
45 Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy Vincenzo Scattoni, Massimo Lazzeri, Giovanni Lughezzani et al. · The Journal of Urology 2 Mar 2013 100
46 Incisional hernia and fascial defect following laparoscopic surgery. Andrea Coda, Maurizio Bossotti, Fabrizio Ferri et al. · Surgical Laparoscopy Endoscopy & Percutaneous Techniques Oct 1999 98
47 Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver Giovanni Musso, Elena Paschetta, Roberto Gambino et al. · Trends in Molecular Medicine ReviewOpen access 29 Jun 2013 97
48 Pegylated Interferon Alfa-2b Plus Ribavirin in the Retreatment of Interferon-Ribavirin Nonresponder Patients Gloria Taliani, Giulia Gemignani, Carlo I. Ferrari et al. · Gastroenterology Open access Apr 2006 97
49 Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials Giovanni Musso, Roberto Gambino, Maurizio Cassader et al. · BMJ ReviewOpen access 9 Apr 2019 95
50 Atrial fibrillation in a large population with Brugada electrocardiographic pattern: Prevalence, management, and correlation with prognosis Carla Giustetto, Natascia Cerrato, Elena Gribaudo et al. · Heart Rhythm Open access 25 Oct 2013 93

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.